期刊文献+

脂质成分与代谢在帕金森病发生中的研究进展

Insights into Lipid Metabolism and Composition in Parkinson's Disease Pathogenesis
下载PDF
导出
摘要 帕金森病(PD)是一种神经系统慢性退行性疾病,其患病人数逐年增多,脂质既具有结构功能又具有生理作用,在大脑结构的发育过程以及维持神经细胞的正常生理活动中发挥着至关重要的作用。脂质代谢参与了PD的病理进展。综述主要总结了PD中的脂代谢异常及其造成的病理损伤,以及基于脂类代谢的治疗、相关药物研究方向的进展和未来的前景。 Parkinson's disease(PD)is a chronic degenerative disorder of the nervous system.Lipids,as fundamental components of cells,are integral to both structural functions and physiological roles.They are essential for the development of brain structures and the maintenance of normal physiological activity in nerve cells.Lipid metabolism is intricately involved in the pathological progression of PD.This review primarily summarizes the abnormalities in lipid metabolism observed in PD,the resultant pathological damage,and lipid metabolism-based therapeutic strategies.Additionally,it discusses recent advancements in related drug research and explores future prospects in this field.
作者 裴晓雪 陈珈萱 宋传锦 王少松 崔莹雪 Pei Xiaoxue;Chen Jiaxuan;Song Chuanjin;Wang Shaosong;Cui Yingxue(Graduate School of Beijing University of Chinese Medicine,Beijing 100029;Acupuncture and Moxibustion Center in Beijing Hospital of Traditional Chinese Medicine of Capital Medical University,Key Laboratory of Acupuncture and Moxibustion Neuromodulation in Beijing,Beijing 100010)
出处 《国际老年医学杂志》 2024年第6期723-728,共6页 International Journal of Geriatrics
基金 北京市属医院科研培育计划项目(PZ20231011)。
关键词 帕金森病 脂质成分 脂质代谢 神经退行性疾病 Parkinson's disease Lipid components Lipid metabolism Neurodegenerative diseases
  • 相关文献

参考文献5

二级参考文献54

  • 1Hui Deng,Weimin Li.Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy,neurological and metabolic disorders[J].Acta Pharmaceutica Sinica B,2020,10(4):582-602. 被引量:10
  • 2张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:617
  • 3陈海波,王新德.统一帕金森病评定量表[J].中华老年医学杂志,1999,18(1):61-62.
  • 4Jenner P. Oxidative stress in Parkinson’s disease [J]. Ann Neurol,2003,53(Suppl 3):S26-S36.
  • 5Gao X,Simon KC,Schwarzschild MA,et al. Prospective study ofstatin use and risk of Parkinson disease [J ]. Arch Neurol, 2012,69?3):380-384.
  • 6Gao J,Huang X,Park Y,et al.Apolipoprotein E genotypes and therisk of Parkinson disease [J ].Neurobiol Aging, 2011,32( 11) :el-6.
  • 7Huang X,Abbott RD, Petrovitch H,et al.Low LDL chohsterol andincreased risk of Parkinson’s disease:prospective results fromHonohlu-Asia Aging Study [j].Mov Disord,2008,23 (7) : 1013 -1018.
  • 8Grandinetti A,Morens DM, Reed D,et al.Prospective study ofcigarette smoking and the risk of developing idiopathic Parkinson’sdisease[j]. Am J Epidemiol, 1994,139( 12): 1129-1138.
  • 9Ikeda K,Nakamura Y,Kiyozuka T,et al.Serological profiles of urate,paraoxonase -1,ferritin and lipid in Parkinson's disease: changeslinked to disease progression[ jj.Neurodegener Dis,2011,8(4) :252-258.
  • 10Qiang JK, Wong YC,Siderowf A ,et al. Plasma apolipoprotein Al as abiomarker for Parkinson disease [j]. Ann Neurol,2013,74( 1) : 119-127.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部